Antidepressant Shines in Phase 2 Trial, but FDA Voices Concerns - Medscape

Submitted by Anonymous (not verified) on Wed, 08/11/2021 - 21:20

Antidepressant Shines in Phase 2 Trial, but FDA Voices Concerns  Medscape